icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
The Liver Meeting
Boston MA
November 2016
Back grey_arrow_rt.gif
 
 
 
Development of Second Generation RNA Interference Therapy for Hepatitis B Virus Infection
 
 
  Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
 
Emily P. Thi1, Xin Ye1, Ammen P. Dhillon1, Nicholas M. Snead1, Andrew S. Kondratowicz1, Alice H. L. Li1, Luying Pei1, Kyle D. Cobarrubias1,Agnes Jarosz1, Joseph Wasney1, Andrea Cuconati2, Rene Rijnbrand2, Michael J. Sofia2, Amy C. H. Lee1
1 Arbutus Biopharma Corp, Burnaby, BC, Canada 2 Arbutus Biopharma Inc, Doylestown, PA, United States

HCV1

HCV2

HCV3

HCV4

HCV5

HCV6

HCV7